Johnson & Johnson Vision Receives FDA Clearance and CE Mark for Next-Generation Phacoemulsification Machine, VERITAS™ Vision System

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Author(s): PR Newswire
  • Source:
    PR Newswire US. 04/21/2021.
  • Additional Information
    • Alternate Title:
      J&J-Vision-VERITAS
    • Subject Terms:
      Israel; Bahrain; Iran; Iraq; Jordan; Kuwait; Lebanon; Oman; Palestine; Qatar; Saudi Arabia; Syria; United Arab Emirates; Yemen; California
    • Abstract:
      SANTA ANA, Calif., April 21, 2021 /PRNewswire/ -- Johnson & Johnson Vision*, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies**, today announced the FDA 510(k) clearance and CE mark of its next-generation phacoemulsification innovation, the VERITAS™ Vision System1. The high-performance phacoemulsification system features technologies that allow surgeons to guide through any lens density with less surge and more stability. The new system also provides advancements in ergonomics to further enhance usability during cataract surgery. [ABSTRACT FROM PUBLISHER]